Brief: Elekta Sets EBIT Margin Target Of At Least 14% Beyond Current Fiscal Year

Elekta AB (publ)

28/08/2024 06:40

Aug 28 (Reuters) - Elekta AB (publ)  EKTAb.ST :
    * NET SALES FOR ELEKTA ARE EXPECTED TO GROW BY MID-SINGLE
DIGIT
FOR THE FULL YEAR OF 2024/25 WITH AN IMPROVED EBIT MARGIN
SUPPORTED BY THE RECENT PRODUCT LAUNCH ELEKTA EVO
    * BEYOND THIS FISCAL YEAR, WE WILL DRIVE FOR AN EBIT MARGIN
OF 14%
OR HIGHER
    * WE ARE EXPERIENCING STRONG CUSTOMER INTEREST IN OUR
INDUSTRY
LEADING OFFERINGS AND LONG-TERM UNDERLYING DEMAND FOR 
WORLD-LEADING CANCER CARE SOLUTIONS

Source text for Eikon:  ID:nMFN7bZcFs 
Further company coverage:  EKTAb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))